Budesonide + Formoterol is a widely prescribed inhalation therapy designed to provide long-term control of asthma and chronic obstructive pulmonary disease (COPD). Asthma and COPD are conditions characterized by airway inflammation, narrowing, and recurrent episodes of breathlessness, coughing, and wheezing. Budesonide, a corticosteroid, works by reducing swelling and inflammation in the airways, thereby preventing the triggers that lead to breathing difficulties. Formoterol, a long-acting bronchodilator, complements this action by relaxing the muscles around the air passages, allowing them to widen and enabling smoother airflow into the lungs. Together, these two agents provide a synergistic effect that not only improves lung function but also reduces the frequency and severity of respiratory flare-ups. This combination is particularly beneficial for patients who require more than one medicine to keep their symptoms under control. Budesonide + Formoterol is used as a maintenance therapy, meaning it is taken regularly to keep symptoms at bay rather than to provide immediate relief during sudden attacks. By ensuring consistent control of airway inflammation and obstruction, it helps patients achieve better quality of life, improved exercise tolerance, and reduced risk of complications associated with uncontrolled asthma or COPD.